Carl Russo - Jan 25, 2024 Form 4 Insider Report for CALIX, INC ((CALX))

Role
Director, 10%+ Owner
Signature
/s/ Tom Gemetti as Attorney-in-Fact for Carl Russo
Stock symbol
(CALX)
Transactions as of
Jan 25, 2024
Transactions value $
$981,600
Form type
4
Date filed
1/29/2024, 04:53 PM
Previous filing
May 19, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction (CALX) Common Stock Options Exercise $982K +120K +3.31% $8.18 3.75M Jan 25, 2024 Direct
holding (CALX) Common Stock 2.24M Jan 25, 2024 See Footnote F1
holding (CALX) Common Stock 285K Jan 25, 2024 See Footnote F2
holding (CALX) Common Stock 276K Jan 25, 2024 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction (CALX) Stock Option (right to buy) Options Exercise $0 -120K -100% $0.00* 0 Jan 25, 2024 Common Stock 120K $8.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by The Crescentico Trust, Carl Russo, Trustee.
F2 Shares held by Calgrat Partners, L.P. The managing partner of Calgrat Partners, L.P. is Tim Pasquinelli. Carl Russo and Tim Pasquinelli may be deemed to have shared voting and investment power over the shares held by Calgrat Partners, L.P. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F3 Shares held by Equanimous Investments. The managing members of Equanimous Investments are Carl Russo and Tim Pasquinelli. These individuals may be deemed to have shared voting and investment power over the shares held by Equanimous Investments. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F4 100% of the shares subject to the option were fully vested and exercisable on January 28, 2018.